Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion type Assertion NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_head.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion description "[These results indicate that upregulation of GATA-2 may contribute to the progression to aggressive prostate cancer through modulation of expression of AR and key androgen-regulated genes, one of which, AZGP1, is associated with the progression to metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_provenance.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion evidence source_evidence_literature NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_provenance.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion SIO_000772 19684615 NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_provenance.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion wasDerivedFrom befree-20150227 NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_provenance.
- NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_assertion wasGeneratedBy ECO_0000203 NP419076.RAmv-n18n-LbHPTjrUFwlVAvFH-A0vhUDj5GFQdhc3AWk130_provenance.